Abstract:Background: Germline pathogenic variants impairing the caspase recruitment domain family member 11 (CARD11)-B cell chronic lymphocytic leukemia/lymphoma 10 (BCL10)-MALT1 paracaspase (MALT1) (CBM) complex are associated with diverse human diseases including combined immunodeficiency (CID), atopy, and lymphoproliferation. However, the impact of CARD11 deficiency on human B-cell development, signaling, and function is incompletely understood. Objectives: This study sought to determine the cellular, immunological, and biochemical basis of disease for 2 unrelated patients who presented with profound CID associated with viral and fungal respiratory infections, interstitial lung disease, and severe colitis. Methods: Patients underwent next-generation sequencing, immunophenotyping by flow cytometry, signaling assays by immunoblot, and transcriptome profiling by RNA-sequencing. Results: Both patients carried identical novel pathogenic biallelic loss-of-function variants in CARD11 (c.2509C>T; p.Arg837∗) leading to undetectable protein expression. This variant prevented CBM complex formation, severely impairing the activation of nuclear factor-κB, c-Jun N-terminal kinase, and MALT1 paracaspase activity in B and T cells. This functional defect resulted in a developmental block in B cells at the naive and type 1 transitional B-cell stage and impaired circulating T follicular helper cell (cTFH) development, which was associated with impaired antibody responses and absent germinal center structures on lymph node histology. Transcriptomics indicated that CARD11-dependent signaling is essential for immune signaling pathways involved in the development of these cells. Both patients underwent hematopoietic stem cell transplantations, which led to functional normalization. Conclusions: Complete human CARD11 deficiency causes profound CID by impairing naive/type 1 B-cell and cTFH cell development and abolishing activation of MALT1 paracaspase, NF-κB, and JNK activity. Hematopoietic stem cell transplantation functionally restores impaired signaling pathways.

Loss of human ICOSL results in combined immunodeficiency.

Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation

A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis

IL-7-dependent and -independent lineages of IL-7R-dependent human T cells

Combined immunodeficiency caused by a novel homozygous NFKB1 mutation

Identification of novel NFKB1 and ICOS frameshift variants in patients with CVID

Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency

A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency

A Nonsense Mutation in IKBKB Causes Combined Immunodeficiency.

Inherited human c-Rel deficiency disrupts myeloid and lymphoid immunity to multiple infectious agents

Whole-Exome Sequencing Reveals IKBKB As a Cause of Combined Immunodeficiency

Human BCL10 Deficiency due to Homozygosity for a Rare Allele

Dominant Combined Immunodeficiency Associated With A Heterozygous Intragenic Deletion In Irf4.

Dual T Cell– and B Cell–intrinsic Deficiency in Humans with Biallelic RLTPR Mutations

Human PLCG2 haploinsufficiency results in a novel natural killer cell immunodeficiency

Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections

Single-cell Atlas of common variable immunodeficiency shows germinal center-associated epigenetic dysregulation in B-cell responses

Case report: Primary immunodeficiency due to a novel mutation in CARMIL2 and its response to combined immunomodulatory therapy

A Novel Homozygous Mutation Destabilizes Ikk Beta And Leads To Human Combined Immunodeficiency

Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function

A human immunodeficiency syndrome caused by mutations in CARMIL2